⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTYX News
Ventyx Biosciences, Inc. Common Stock
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
accessnewswire.com
VTYX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
accessnewswire.com
VTYX
VectorY Therapeutics Receives FDA Clearance of IND to Proceed with the PIONEER-ALS Phase 1/2 Trial of VTx-002, a First-in-Class Vectorized Antibody Targeting TDP-43 Pathology in ALS
businesswire.com
VTYX
Ventyx Provides Clinical and Corporate Updates
globenewswire.com
VTYX
Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference
globenewswire.com
VTYX
Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference in London
globenewswire.com
VTYX
Ventyx Biosciences Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress
globenewswire.com
VTYX